Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Details : Pazopanib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Macular Degeneration.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 30, 2011
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pazopanib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Macular Degeneration.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 30, 2010
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
Details : Pazopanib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Macular Degeneration.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 31, 2010
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers
Details : Pazopanib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Macular Degeneration.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 22, 2010
Lead Product(s) : Pazopanib Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
